Nadolol
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1441 publications
Impact of green tea on pharmacokinetics in cardiovascular therapy: current insights.
Journal: Expert opinion on drug metabolism & toxicology
Published: April 07, 2026
Nonselective Beta Blockers Are Beneficial in Patients with Cirrhotic Ascites and Spontaneous Bacterial Peritonitis: A Propensity-Matched Study.
Journal: Journal of clinical medicine
Published: January 23, 2026
Photocatalytic Degradation of an Aromatic Pharmaceutical over TiO2: Experimental and Computational Insights into Inhibition Effects of Natural Organic Acids.
Journal: Molecules (Basel, Switzerland)
Published: January 22, 2026
Effects of matcha green tea on the pharmacokinetics of nadolol in rats.
Journal: PloS one
Published: October 23, 2025
Breastfeeding During Maternal Nadolol Therapy for Long QT Syndrome: Five-Month Infant Follow-Up.
Journal: Pediatric cardiology
Published: October 22, 2025
Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker.
Journal: Pharmacology research & perspectives
Published: October 20, 2025
Exploring Nadolol as a Therapeutic Option for Infantile Hemangioma: A Narrative Review.
Journal: Cureus
Published: October 19, 2025
Fate, chlorination kinetics, and comprehensive risk assessment of pharmaceuticals and personal care products in drinking water distribution systems.
Journal: Journal of contaminant hydrology
Published: October 09, 2025
Association of nonselective β blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysis.
Journal: Annals of hepatology
Published: September 18, 2025
Impact of β-Blockers on the Risk of Low-Birth-Weight Infants in Women with Long QT Syndrome or Marfan Syndrome: A Single-Center Retrospective Study from 2008 to 2022 in a Tertiary Care Center.
Journal: Paediatric drugs
Published: August 12, 2025
Last Updated: 04/28/2026